High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators

Elina Mattila, Johanna Ivaska

Research output: Contribution to journalArticleScientificpeer-review

8 Citations (Scopus)

Abstract

Reversible protein tyrosine phosphorylation, catalysed by the counter-actors protein tyrosine phosphatases (PTPs) and protein tyrosine kinases (PTKs), is a fundamentally important regulatory mechanism of proteins in living cells, controlling cell communication, proliferation, differentiation, motility, and molecular trafficking. The activities of PTPs and PTKs are derailed in several diseases such as cancer and type II diabetes, making them attractive drug targets. Developing drugs against PTKs has started a decade earlier than that on PTPs, and at present there are several molecules targeting PTKs on the market. PTPs in turn are of raising interest, with PTP1B on the lead for its effects on type II diabetes and obesity. In the search for modulators of PTP activity, high-throughput methods are important as the initial step to find suitable lead compounds for drug development. Also, high-throughput methods are very useful in elucidating the specific function of different PTPs. In this review, the different high-throughput studies performed to find inhibitors and activators of classical PTPs are discussed.
Original languageEnglish
Pages (from-to)141-150
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume11
Issue number1
DOIs
Publication statusPublished - 2011
MoE publication typeA1 Journal article-refereed

Fingerprint

Protein Tyrosine Phosphatases
Protein-Tyrosine Kinases
Type 2 Diabetes Mellitus
Pharmaceutical Preparations
Cell Communication
Tyrosine
Proteins
Obesity
Phosphorylation
Cell Proliferation

Keywords

  • High throughput screens (HTS)
  • TCPTP
  • SHP-2
  • LAR
  • LYP
  • CD45
  • RTK
  • DiFMUP
  • pNPP
  • HTS
  • OMFP

Cite this

@article{255e92a540b943059e27b9aa293afbc7,
title = "High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators",
abstract = "Reversible protein tyrosine phosphorylation, catalysed by the counter-actors protein tyrosine phosphatases (PTPs) and protein tyrosine kinases (PTKs), is a fundamentally important regulatory mechanism of proteins in living cells, controlling cell communication, proliferation, differentiation, motility, and molecular trafficking. The activities of PTPs and PTKs are derailed in several diseases such as cancer and type II diabetes, making them attractive drug targets. Developing drugs against PTKs has started a decade earlier than that on PTPs, and at present there are several molecules targeting PTKs on the market. PTPs in turn are of raising interest, with PTP1B on the lead for its effects on type II diabetes and obesity. In the search for modulators of PTP activity, high-throughput methods are important as the initial step to find suitable lead compounds for drug development. Also, high-throughput methods are very useful in elucidating the specific function of different PTPs. In this review, the different high-throughput studies performed to find inhibitors and activators of classical PTPs are discussed.",
keywords = "High throughput screens (HTS), TCPTP, SHP-2, LAR, LYP, CD45, RTK, DiFMUP, pNPP, HTS, OMFP",
author = "Elina Mattila and Johanna Ivaska",
year = "2011",
doi = "10.2174/187152011794941235",
language = "English",
volume = "11",
pages = "141--150",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "Bentham Science Publishers",
number = "1",

}

High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators. / Mattila, Elina; Ivaska, Johanna.

In: Anti-Cancer Agents in Medicinal Chemistry, Vol. 11, No. 1, 2011, p. 141-150.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - High-throughput methods in identification of protein tyrosine phosphatase inhibitors and activators

AU - Mattila, Elina

AU - Ivaska, Johanna

PY - 2011

Y1 - 2011

N2 - Reversible protein tyrosine phosphorylation, catalysed by the counter-actors protein tyrosine phosphatases (PTPs) and protein tyrosine kinases (PTKs), is a fundamentally important regulatory mechanism of proteins in living cells, controlling cell communication, proliferation, differentiation, motility, and molecular trafficking. The activities of PTPs and PTKs are derailed in several diseases such as cancer and type II diabetes, making them attractive drug targets. Developing drugs against PTKs has started a decade earlier than that on PTPs, and at present there are several molecules targeting PTKs on the market. PTPs in turn are of raising interest, with PTP1B on the lead for its effects on type II diabetes and obesity. In the search for modulators of PTP activity, high-throughput methods are important as the initial step to find suitable lead compounds for drug development. Also, high-throughput methods are very useful in elucidating the specific function of different PTPs. In this review, the different high-throughput studies performed to find inhibitors and activators of classical PTPs are discussed.

AB - Reversible protein tyrosine phosphorylation, catalysed by the counter-actors protein tyrosine phosphatases (PTPs) and protein tyrosine kinases (PTKs), is a fundamentally important regulatory mechanism of proteins in living cells, controlling cell communication, proliferation, differentiation, motility, and molecular trafficking. The activities of PTPs and PTKs are derailed in several diseases such as cancer and type II diabetes, making them attractive drug targets. Developing drugs against PTKs has started a decade earlier than that on PTPs, and at present there are several molecules targeting PTKs on the market. PTPs in turn are of raising interest, with PTP1B on the lead for its effects on type II diabetes and obesity. In the search for modulators of PTP activity, high-throughput methods are important as the initial step to find suitable lead compounds for drug development. Also, high-throughput methods are very useful in elucidating the specific function of different PTPs. In this review, the different high-throughput studies performed to find inhibitors and activators of classical PTPs are discussed.

KW - High throughput screens (HTS)

KW - TCPTP

KW - SHP-2

KW - LAR

KW - LYP

KW - CD45

KW - RTK

KW - DiFMUP

KW - pNPP

KW - HTS

KW - OMFP

U2 - 10.2174/187152011794941235

DO - 10.2174/187152011794941235

M3 - Article

VL - 11

SP - 141

EP - 150

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 1

ER -